| Sean Mullendore, MD | |
|
3308 Samson Way, Suite 101, Bellevue, NE 68123-3194 | |
| (402) 827-1577 | |
| (402) 898-3134 |
| Full Name | Sean Mullendore |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 3308 Samson Way, Bellevue, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821081365 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | 21562 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Home Care | Bellevue, NE | Home health agency |
| Chi Health Bergan Mercy | Omaha, NE | Hospital |
| Chi Health Midlands | Papillion, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
The drug memantine can reduce cognitive deterioration and loss of everyday functions in patients with moderate to severe Alzheimer's disease, according to a new review of studies.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
› Verified 8 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548287907 PECOS PAC ID: 1951210418 Enrollment ID: O20040407001314 |
News Archive
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
The drug memantine can reduce cognitive deterioration and loss of everyday functions in patients with moderate to severe Alzheimer's disease, according to a new review of studies.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Mullendore, MD Po Box 642117, Omaha, NE 68164-8117 Ph: (402) 717-4377 | Sean Mullendore, MD 3308 Samson Way, Suite 101, Bellevue, NE 68123-3194 Ph: (402) 827-1577 |
News Archive
Patients on long-term anticoagulation therapy who test their own blood-clotting time from home and continue to be managed by their GP are significantly less likely to experience a thromboembolic event, according to Oxford University researchers.
The drug memantine can reduce cognitive deterioration and loss of everyday functions in patients with moderate to severe Alzheimer's disease, according to a new review of studies.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in its Phase I/IIa clinical program evaluating the company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in combination with standard antiviral treatment and vaccination in HBeAg-negative chronic hepatitis B-infected (HBV) patients.
The earlier that autism is diagnosed and treated in children, the better outcomes they will experience for future relationships and careers.
› Verified 8 days ago
Dr. James I Wax, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2206 Longo Drive Suite 210, Bellevue, NE 68005 Phone: 402-292-5594 Fax: 402-292-5832 | |
Dr. Joseph S Miller, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1902 Harlan Dr, Bellevue, NE 68005 Phone: 402-682-4165 Fax: 402-934-2291 | |
Dr. Jeremy C King, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 Fax: 402-595-1970 | |
Holly Lynn Groteluschen, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2510 Bellevue Medical Center Dr Ste 200, Bellevue, NE 68123 Phone: 402-595-2275 | |
Brian J Finley, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 Bellevue Medical Center Dr, Ste 145a, Bellevue, NE 68123 Phone: 402-779-7207 Fax: 402-779-7210 | |
Kevin B Jones, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 3308 Samson Way Ste 102, Bellevue, NE 68123 Phone: 402-291-3373 | |
Dr. Khalil John Burhan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3308 Samson Way, Bellevue, NE 68123 Phone: 402-827-1577 Fax: 402-898-3134 |